Healthcare -
Biotechnology - NASDAQ - US
$ 32.795
0.506 %
$ 3.91 B
Market Cap
-11.39
P/E
Price Target
Average
66.18%
Revenue Forecast
Estimate
348.41%
EBIT
Estimate
--54.09%
Net Income
Estimate
36.18%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Avidity Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for RNA of $54.5 , with forecasts ranging from
a
low of
$50 to a high of $59 .
RNA Lowest Price Target
Wall Street Target
50 USD
52.46%
RNA Average Price Target
Wall Street Target
54.5 USD
66.18%
RNA Highest Price Target
Wall Street Target
59 USD
79.91%
REVENUE FORECAST
Revenue Forecast Chart RNA
EBIT FORECAST
EBIT Forecast Chart RNA
NET INCOME FORECAST
Net Income Chart RNA